SB 197 – ConnecticutStatus: Enacted
Year Introduced: 2018
BIOLOGICAL PRODUCTS: Concerns biological products, adds biological products to existing law regarding substitution of generic drugs. Requires that within 48-hours of dispensing that the pharmacist shall inform the prescribing practitioner by facsimile, telephone or electronic transmission of the biosimilar substitution.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.